Erenumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Erenumab Usage And Synthesis

Uses

Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1].

References

[1] Goadsby PJ, Reuter U, Hallstr?m Y, et al. A Controlled Trial of Erenumab for Episodic Migraine.?N Engl J Med. 2017;377(22):2123-2132. DOI:10.1056/NEJMoa1705848

Erenumab(1582205-90-0)Related Product Information

• ipilimumab
• Cusatuzumab
• Dacetuzumab
• Cibisatamab
• Selicrelumab
• Galcanezumab
• Rovalpituzumab
• Tinurilimab
• Zolbetuximab
• Eculizumab